Identification of biochemical determinants for diagnosis and prediction of severity in 5q spinal muscular atrophy using 1H-nuclear magnetic resonance metabolic profiling in patient-derived biofluids
This study explores the potential of 1H-NMR spectroscopy-based metabolic profiling in various biofluids as a diagnostic and predictive modality to assess disease severity in individuals with 5q spinal muscular atrophy. A total of 213 biosamples (urine, plasma, and CSF) from 153 treatment-naïve pati...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 November 2024
|
| In: |
International journal of molecular sciences
Year: 2024, Volume: 25, Issue: 22, Pages: 1-19 |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms252212123 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms252212123 Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/25/22/12123 |
| Author Notes: | Afshin Saffari, Moritz Niesert, Claire Cannet, Astrid Blaschek, Andreas Hahn, Jessika Johannsen, Musa Kockaya, Heike Kölbel, Georg F. Hoffmann, Peter Claus, Stefan Kölker, Wolfgang Müller-Felber, Andreas Roos, Ulrike Schara-Schmidt, Friedrich K. Trefz, Katharina Vill, Wolfgang Wick, Markus Weiler, Jürgen G. Okun and Andreas Ziegler |
| Summary: | This study explores the potential of 1H-NMR spectroscopy-based metabolic profiling in various biofluids as a diagnostic and predictive modality to assess disease severity in individuals with 5q spinal muscular atrophy. A total of 213 biosamples (urine, plasma, and CSF) from 153 treatment-naïve patients with SMA across five German centers were analyzed using 1H-NMR spectroscopy. Prediction models were developed using machine learning algorithms which enabled the patients with SMA to be grouped according to disease severity. A quantitative enrichment analysis was employed to identify metabolic pathways associated with disease progression. The results demonstrate high sensitivity (84-91%) and specificity (91-94%) in distinguishing treatment-naïve patients with SMA from controls across all biofluids. The urinary and plasma profiles differentiated between early-onset (type I) and later-onset (type II/III) SMA with over 80% accuracy. Key metabolic differences involved alterations in energy and amino acid metabolism. This study suggests that 1H-NMR spectroscopy based metabolic profiling may be a promising, non-invasive tool to identify patients with SMA and for severity stratification, potentially complementing current diagnostic and prognostic strategies in SMA management. |
|---|---|
| Item Description: | Die Ziffer 1 ist im Titel hochgestellt Gesehen am 20.05.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms252212123 |